CLINICAL_TRIALS ClinicalTrials.gov record update

Androgen Receptor Targeting in Mantle Cell Lymphoma: A Pilot Trial of Enzalutamide

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02489123
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:04.355717+00:00
Published At: 2021-08-10T00:00:00+00:00
Record Updated At: 2021-08-10
Results Posted At: 2021-08-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Ann Arbor Stage I Mantle Cell Lymphoma", "Ann Arbor Stage II Mantle Cell Lymphoma", "Ann Arbor Stage III Mantle Cell Lymphoma", "Ann Arbor Stage IV Mantle Cell Lymphoma", "Recurrent Mantle Cell Lymphoma", "Refractory Mantle Cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-08-10"
protocolSection.identificationModule.nctId: "NCT02489123"
protocolSection.identificationModule.officialTitle: "Androgen Receptor Targeting in Mantle Cell Lymphoma: A Pilot Trial of Enzalutamide"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-08-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.